Tirzepatide vs Semaglutide

Is tirzepatide better than semaglutide?

This is the rare pair where the question has a real answer, because a genuine head-to-head trial was run: SURMOUNT-5 compared the two directly for weight loss and tirzepatide produced the larger reduction. Both are FDA-approved, so both are prescribable medicines rather than grey-market material. But 'better' depends on which outcome you mean — semaglutide carries the more established cardiovascular outcomes evidence and an oral formulation, and it is the more studied of the two by a wide margin.

Head-to-head evidence

SURMOUNT-5 randomised participants directly between tirzepatide and semaglutide for weight management over 72 weeks and reported a larger mean reduction on tirzepatide. It is the strongest direct evidence available on this pair — and it measured weight, not cardiovascular events, not durability past the trial, and not what happens after either drug is stopped.

A common mistake

Treating a weight-loss result as a general ranking. SURMOUNT-5 answered one endpoint. On cardiovascular outcomes evidence, the same two drugs are ordered the other way around.

Educational use only, never medical advice. No doses.